APOC2 and hyperlipidemia: The enrichment analysis revealed that 27-hydroxylase deficiency, 3-phosphoglyceratedehydrogenase deficiency, apolipoprotein C-II deficiency cholesteryl ester storage disease glycogenosis, type IXB, acute myelogenous leukemia, congenital disorder of glycosylation CDG-IA, congenital disorder of glycosylation CDG-IB, fish-eye disease, hyperlipidemia, mevalonic aciduria, oculocerebrorenal syndrome of Lowe, phosphoserine aminotransferase deficiency-new disorder, and Sotos syndrome were the enrichment entries most significantly implicated for cheese consumption (Figure 6A).